SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein | 39-115

SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein | 39-115 | Gentaur UK, US & Europe Distribution

Tested Application: N/A

Application: N/A

Tpredicted Molecular Weight: N/A

Physical State: Liquid

Buffer: CoV 2019 Nucleocapsid-Mosaic Protein solution is supplied in 1x PBS.

Storage Condition: Store in working aliquots at -20˚C. Avoid freeze/thaw cycles.

Alternate Name: N/A

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: E. coli

Species: SARS-CoV-2

By Source: E. coli

By Species: Other

Fusion Tag: His Tag

Sequence: The E.Coli derived recombinant protein contains the Coronavirus 2019 full length nuclepocapsid Mosaic immunodominant regions [ full length N-antigen ], fused to 6xHis tag at C-terminal.

Bological Activity: N/A

Purity: >90% pure as determined SDS-PAGE.